General Practice · Los Angeles, CA
NPI
1225193964
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
652 N Broadway # A
Los Angeles, CA, 90012
Phone (213) 617-7673
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
7,292 services
Medicare patients, 2024
384
Average age 80
Drug cost, 2024
$3.0M
33,426 prescriptions
Company payments, 2025
$4,493
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhaoyang Pan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 2,873 times for 342 patients. In total Zhaoyang Pan billed 7,292 services in 34 codes, and Medicare paid $374K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,873 | 342 | $13.02 | $37K |
| 99213 Office E&M - Established | Office | 2,505 | 318 | $73.68 | $185K |
| 99214 Office E&M - Established | Office | 467 | 236 | $103.38 | $48K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 267 | 267 | $140.45 | $38K |
| 99308 SNF E&M | Facility | 215 | 24 | $62.68 | $13K |
| G0008 Administration of influenza virus vaccine | Office | 196 | 192 | $35.02 | $6,864 |
| 99212 Office E&M - Established | Office | 176 | 100 | $48.57 | $8,549 |
| 90661 Vaccine Product | Office | 102 | 102 | $36.11 | $3,683 |
| 36410 Vascular | Office | 91 | 81 | $14.76 | $1,343 |
| 90653 Vaccine Product | Office | 87 | 87 | $81.82 | $7,118 |
| 96372 Injection Administration | Office | 52 | 35 | $12.55 | $652 |
| 99443 Telephone Services | Office | 36 | 27 | $101.70 | $3,661 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 35 | 12 | $0.09 | $3.16 |
| 99203 Office E&M - New | Office | 29 | 29 | $76.99 | $2,233 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 26 | 24 | $242.95 | $6,317 |
By year: 2022 $367K for 5,010 services; 2023 $329K for 4,420 services; 2024 $374K for 7,292 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zhaoyang Pan prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,732 prescriptions and refills. In total Zhaoyang Pan wrote 33,426 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,732 | 2,732 | 369 | $14K |
| Losartan Potassium Generic | 1,547 | 2,521 | 326 | $13K |
| Amlodipine Besylate Generic | 1,292 | 1,996 | 263 | $5,515 |
| Montelukast Sodium Generic | 1,088 | 1,396 | 303 | $8,071 |
| Celecoxib Generic | 1,034 | 1,234 | 278 | $19K |
| Omeprazole Generic | 834 | 1,172 | 223 | $5,786 |
| Gabapentin Generic | 831 | 973 | 207 | $4,016 |
| Simvastatin Generic | 827 | 1,263 | 167 | $5,335 |
| Olmesartan Medoxomil Generic | 735 | 1,068 | 129 | $8,465 |
| Tamsulosin Hcl Generic | 562 | 792 | 115 | $5,172 |
| Triamcinolone Acetonide Generic | 501 | 531 | 187 | $5,856 |
| Levothyroxine Sodium Generic | 499 | 748 | 101 | $3,810 |
| Azelastine Hcl Generic | 490 | 568 | 146 | $5,810 |
| Metoprolol Succinate Generic | 485 | 768 | 104 | $5,888 |
| Alendronate Sodium Generic | 484 | 730 | 116 | $3,097 |
Brand drugs: 5,001 claims; generic drugs: 28,291 claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhaoyang Pan $4,493 ($4,493 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,050.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $1,050 |
| Amgen Inc. AMGN | 13 | $558 |
| GlaxoSmithKline, LLC. GSK | 23 | $542 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 20 | $415 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $273 |
| Abbvie Inc. ABBV | 10 | $228 |
| Kowa Pharmaceuticals America, Inc. | 10 | $210 |
| Novo Nordisk Inc NVO | 2 | $147 |
| Radius Health, Inc. | 2 | $139 |
| Gilead Sciences, Inc. GILD | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.